Researchers have developed brain-on-a-chip technology that uses human tissue to model how the brain’s protective barrier breaks down during inflammation and disease.

First-ever clinical data supporting safety and efficacy of in vivo CAR-T Therapy in refractory systemic lupus erythematosus (SLE) patients. Data shows low dose of HN2301 reprogrammed up to 60% of CD8 ...

The FDA has granted fast track designation to the investigational therapeutic agent WTX-124 for the potential treatment of ...

BLACKSBURG, Va.--(BUSINESS WIRE)--NImmune Biopharma, (“NImmune”), a private late-clinical-stage precision immunology biopharmaceutical company focused on the discovery and development of best-in-class ...

A growing body of research now suggests that the next wave of progress may not come from a new “miracle drug,” but from a more integrated approach: combining topical therapies with systemic ...